The EU Representative Action Directive: What to expect from Member States
In November 2020, the Representative Action Directive (the Directive) was formally approved by the European Parliament. The new regime,...
I help businesses - mainly in the FMCG, retail, leisure and healthcare sectors - handle commercial disputes, consumer law issues and product liability litigation.
I also help them manage regulatory risks, from advising on product safety and recall to dealing with the approvals needed for a new brand introduction and the risks associated with their marketing claims.
My practice is ranked in Tier 1 in both Legal 500 and Chambers. Legal 500 (2015) says that I am "noted for [my] regulatory know how" and the 2016 edition of Chambers says: "Andrew Austin is a rising talent in product and general commercial liability matters covering both regulatory and litigious aspects. Sources say that he 'offers invaluable support. He is excellent, and always there when you need him. Very articulate, measured and works extremely well under pressure.'"
Having worked in New York, Paris and London during my career at Freshfields, I see myself as having a genuinely international outlook. I particularly enjoy helping US clients navigate the European regulatory and litigation environment. I have a lot of experience in working with other Freshfields network offices and trusted external counsel to coordinate the defence of multi-jurisdictional product liability litigation and regulatory advocacy campaigns.
I joined Freshfields in 1999 and became a partner in 2011. I became our Trainee Recruitment Partner in June 2014. I am proud to form part of the firm's global diversity team and to act as sponsor of its LGBT network group, Halo.
Specialties: Product regulation, food law, consumer law, marketing law, product liability defence, mass torts defence, risk management, regulatory advocacy and engagement, product recall, anti-bribery and corruption, emerging technologies, nanotechnology
In November 2020, the Representative Action Directive (the Directive) was formally approved by the European Parliament. The new regime,...
First EU 'collective actions' under the new Directive likely in 2023
Today the provisional agreement on the proposal for a new Directive...
On 13 November 2020, the European Commission ('the Commission') launched its New Consumer Agenda ('the Agenda') intended to further...
On 13 November 2020, the European Commission ('the Commission') launched its New Consumer Agenda ('the Agenda') intended to further...
The UK’s Competition and Markets Authority (CMA) yesterday discontinued three of its four investigations into pharmacies and convenience...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net